{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:06:44Z","timestamp":1789693604183,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26\/200.862\/2026"],"award-info":[{"award-number":["E-26\/200.862\/2026"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ygyno.2026.08.008","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T13:11:45Z","timestamp":1786453905000},"page":"116-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Persistent low-level real human chorionic gonadotropin after gestational trophoblastic disease: Natural history and predictors of subsequent gestational trophoblastic neoplasia"],"prefix":"10.1016","volume":"212","author":[{"given":"Raphael","family":"Alevato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f4nio","family":"Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Paiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Aurajo J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue Yazaki","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana Giongo","family":"Pedrotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Bessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solange Artimos","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joffre","family":"Amim-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Rezende-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Berkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.ygyno.2026.08.008_bb0005","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1200\/JCO-24-02326","volume":"43","author":"Lok","year":"2025","journal-title":"J. Clin. Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2026.08.008_bb0010","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ijgo.70275","article-title":"Diagnosis and management of gestational trophoblastic disease: 2025 update","volume":"171","author":"Ngan","year":"2025","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"6","key":"10.1016\/j.ygyno.2026.08.008_bb0015","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.hoc.2024.07.001","article-title":"Diagnosis and management of molar pregnancies","volume":"38","author":"Braga","year":"2024","journal-title":"Hematol. Oncol. Clin. North Am."},{"issue":"4","key":"10.1016\/j.ygyno.2026.08.008_bb0020","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/AOG.0000000000005998","article-title":"Etiology, natural history, and management of recent advances in molar pregnancy","volume":"146","author":"Braga","year":"2025","journal-title":"Obstet. Gynecol."},{"issue":"9","key":"10.1016\/j.ygyno.2026.08.008_bb0025","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1136\/ijgc-2020-001237","article-title":"Outcomes in the management of high-risk gestational trophoblastic neoplasia in trophoblastic disease centers in South America","volume":"30","author":"Maest\u00e1","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2026.08.008_bb0030","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ygyno.2020.04.704","article-title":"Gestational trophoblastic neoplasia lethality among Brazilian women: a retrospective national cohort study","volume":"158","author":"Freitas","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.08.008_bb0035","first-page":"433","article-title":"Detection of hCG in trophoblastic disease: the USA hCG reference service experience","volume":"47","author":"Cole","year":"2002","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ygyno.2026.08.008_bb0040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1586\/14737159.9.1.51","article-title":"Human chorionic gonadotropin and associated molecules","volume":"9","author":"Cole","year":"2009","journal-title":"Expert. Rev. Mol. Diagn."},{"issue":"5","key":"10.1016\/j.ygyno.2026.08.008_bb0045","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1067\/mob.2003.271","article-title":"Persistent low levels of human chorionic gonadotropin: a premalignant gestational trophoblastic disease","volume":"188","author":"Khanlian","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.ygyno.2026.08.008_bb0050","first-page":"433","article-title":"What we know about low-level hCG: definition, classification and management","volume":"49","author":"Kohorn","year":"2004","journal-title":"J. Reprod. Med."},{"issue":"4","key":"10.1016\/j.ygyno.2026.08.008_bb0055","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ogc.2005.08.005","article-title":"Gestation trophoblastic diseases: management of cases with persistent low human chorionic gonadotropin results","volume":"32","author":"Cole","year":"2005","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"issue":"2","key":"10.1016\/j.ygyno.2026.08.008_bb0060","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ygyno.2005.12.048","article-title":"Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results","volume":"102","author":"Cole","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2026.08.008_bb0065","first-page":"812","article-title":"Management of gestational trophoblastic disease and other cases with low serum levels of human chorionic gonadotropin","volume":"51","author":"Khanlian","year":"2006","journal-title":"J. Reprod. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2026.08.008_bb0070","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/01443615.2010.536859","article-title":"Characterisation of transient benign hCG elevations in women following chemotherapy for GTT","volume":"31","author":"White","year":"2011","journal-title":"J. Obstet. Gynaecol."},{"issue":"6","key":"10.1016\/j.ygyno.2026.08.008_bb0075","first-page":"443","article-title":"Neinvazivn\u00ed trofoblastick\u00e1 nemoc [Quiscent trophoblastic disease]","volume":"76","author":"Hron","year":"2011","journal-title":"Ceska Gynekol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.08.008_bb0080","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s13669-013-0071-6","article-title":"Management of chemoresistant and quiescent gestational trophoblastic disease","volume":"3","author":"Ngu","year":"2014","journal-title":"Curr. Obstet. Gynecol. Rep."},{"issue":"6","key":"10.1016\/j.ygyno.2026.08.008_bb0085","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/jog.12953","article-title":"Long-term outcome of patients with persistent low-level elevation of human chorionic gonadotrophin","volume":"42","author":"Qian","year":"2016","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"1","key":"10.1016\/j.ygyno.2026.08.008_bb0090","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12905-019-0794-2","article-title":"Spontaneous regression of quiescent gestational trophoblastic disease after pregnancy: a case report","volume":"19","author":"Okada","year":"2019","journal-title":"BMC Womens Health"},{"issue":"Suppl. 2","key":"10.1016\/j.ygyno.2026.08.008_bb0095","first-page":"S130","article-title":"Trophoblastic disease","volume":"119","author":"Ngan","year":"2012","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2026.08.008_bb0100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/ijgo.13877","article-title":"Diagnosis and management of gestational trophoblastic disease: 2021 update","volume":"155","author":"Ngan","year":"2021","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"6","key":"10.1016\/j.ygyno.2026.08.008_bb0105","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/09513590.2015.1132303","article-title":"Persistent low levels of serum hCG due to heterophilic mouse antibodies: an unrecognized pitfall in the diagnosis of trophoblastic disease","volume":"32","author":"Gonz\u00e1lez Aguilera","year":"2016","journal-title":"Gynecol. Endocrinol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.08.008_bb0110","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000531499","article-title":"Measurement of human chorionic gonadotrophin in women with gestational trophoblastic disease","volume":"89","author":"McMahon","year":"2024","journal-title":"Gynecol. Obstet. Investig."},{"issue":"2","key":"10.1016\/j.ygyno.2026.08.008_bb0115","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1097\/AOG.0000000000006155","article-title":"Management of positive human chorionic gonadotropin test results in nonpregnant patients without gynecologic malignancy","volume":"147","author":"ACOG Clinical Consensus No. 11","year":"2026","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.08.008_bb0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2009.09.028","article-title":"Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases","volume":"116","author":"Cole","year":"2010","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.08.008_bb0125","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ygyno.2010.01.016","article-title":"Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases","volume":"117","author":"Seckl","year":"2010","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.08.008_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ygyno.2009.11.006","article-title":"Sweet or low: does hyperglycosylated hCG define a new clinical entity or reveal inadequate care?","volume":"116","author":"Singh","year":"2010","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2026.08.008_bb0135","first-page":"423","article-title":"Inappropriate management of women with persistent low hCG results","volume":"49","author":"Cole","year":"2004","journal-title":"J. Reprod. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2026.08.008_bb0140","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1006\/gyno.2002.6622","article-title":"Persistent low-level \u201creal\u201d human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma","volume":"85","author":"Kohorn","year":"2002","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2026.08.008_bb0145","first-page":"559","article-title":"Management of persistent, unexplained, low-level human chorionic gonadotropin elevation: a report of 5 cases","volume":"49","author":"Hwang","year":"2004","journal-title":"J. Reprod. Med."},{"issue":"5","key":"10.1016\/j.ygyno.2026.08.008_bb0150","first-page":"288","article-title":"A conservative approach in persistent low-level elevation of serum beta-human chorionic gonadotropin following chemotherapy for gestational trophoblastic neoplasia","volume":"54","author":"Boafo-Yirenki","year":"2009","journal-title":"J. Reprod. Med."},{"issue":"7\u20138","key":"10.1016\/j.ygyno.2026.08.008_bb0155","first-page":"317","article-title":"Recurrent gestational trophoblastic disease in a case of suspected quiescent gestational trophoblastic disease: a case report","volume":"55","author":"Sasaki","year":"2010","journal-title":"J. Reprod. Med."},{"issue":"3","key":"10.1016\/j.ygyno.2026.08.008_bb0160","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0020-7292(02)00063-2","article-title":"FIGO Staging for Gestational Trophoblastic Neoplasia 2000. FIGO Oncology Committee","volume":"77","author":"FIGO Oncology Committee","year":"2002","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"Suppl. 2","key":"10.1016\/j.ygyno.2026.08.008_bb0165","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ijgo.12615","article-title":"Update on the diagnosis and management of gestational trophoblastic disease","volume":"143","author":"Ngan","year":"2018","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2026.08.008_bb0170","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/1471-0528.13617","article-title":"Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review","volume":"123","author":"Braga","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.ygyno.2026.08.008_bb0175","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ygyno.2017.09.007","article-title":"Does hormonal contraception during molar pregnancy follow-up influence the risk and clinical aggressiveness of gestational trophoblastic neoplasia after controlling for risk factors?","volume":"147","author":"Dantas","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"23","key":"10.1016\/j.ygyno.2026.08.008_bb0180","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1113\/JP285575","article-title":"Moving beyond P values in the journal of physiology: A primer on the value of effect sizes and confidence intervals","volume":"601","author":"Williams","year":"2023","journal-title":"J. Physiol."},{"issue":"16","key":"10.1016\/j.ygyno.2026.08.008_bb0185","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/sim.1047","article-title":"A solution to the problem of separation in logistic regression","volume":"21","author":"Heinze","year":"2002","journal-title":"Stat. Med."},{"issue":"3","key":"10.1016\/j.ygyno.2026.08.008_bb0190","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ygyno.2016.09.012","article-title":"Is chemotherapy necessary for patients with molar pregnancy and human chorionic gonadotropin serum levels raised but falling at 6months after uterine evacuation?","volume":"143","author":"Braga","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2026.08.008_bb0195","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.placenta.2007.01.011","article-title":"Hyperglycosylated hCG","volume":"28","author":"Cole","year":"2007","journal-title":"Placenta"},{"issue":"2","key":"10.1016\/j.ygyno.2026.08.008_bb0200","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ygyno.2005.12.045","article-title":"Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia","volume":"102","author":"Cole","year":"2006","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826021001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826021001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:43:13Z","timestamp":1789692193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825826021001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":40,"alternative-id":["S0090825826021001"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.08.008","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistent low-level real human chorionic gonadotropin after gestational trophoblastic disease: Natural history and predictors of subsequent gestational trophoblastic neoplasia","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}